MyMD Pharmaceuticals, Inc. (MYMD) Financials

MYMD Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 21.8 million 5.7 million
2023-06-30 25.2 million 14.5 million
2023-03-31 28.4 million 14.4 million
2022-12-31 17.5 million 2.8 million

MYMD Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -3.2 million 385143
2023-06-30 -3.9 million 1.0 million
2023-03-31 -4.0 million 19908
2022-12-31 -2.2 million 45222

MYMD Net Income

No data available :(

MYMD Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 8.5 million - 93145
2023-06-30 11.6 million - 109792
2023-03-31 15.5 million - 126031
2022-12-31 4.8 million - 141721

MYMD Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 44.9 million
2023-06-30 40.4 million
2023-03-31 39.8 million
2022-12-31 38.8 million

MYMD Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 1.9 million 1.9 million -
2023-06-30 - 2.2 million 3.6 million -
2023-03-31 - 770430 1.1 million -
2022-12-31 - 2.5 million 1.3 million -

MYMD Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - -
2023-06-30 - -
2023-03-31 - -
2022-12-31 - -

MYMD

Price: $2.84

52 week price:
2.07
70.50

Earnings Per Share: -5.10 USD

P/E Ratio: -0.82

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 304100

Market Capitalization: 5.4 million

Links: